ACADIA Pharmaceuticals Inc.
NASDAQ:ACADBiotechnology
Healthcare
$17.83 -0.60%
-$0.13 today
- Market cap
- $3.08B
- Beta
- 0.83
- P/E (TTM)
- 9.7
- EPS (TTM)
- $2.20
52W Low $19.69High $28.35
Volume 1.89M
Average 1.66M
News
For ACADIA Pharmaceuticals Inc., read summarized stories built from several publishers and recent headlines with links to the original coverage.
Stories
All market newsNo stories for ACAD yet. A story appears once at least three publishers cover the same event.
More headlines
Recent coverage that has not been summarized. Links open the publisher's site.
- ACADIA Pharmaceuticals Eyes Deals as DAYBUE Growth Fuels Revenue Surge
MarketBeat
- Acadia Pharmaceuticals Inc. (ACAD) Presents at UBS Global Biopharma Conference 2026 Transcript
Seeking Alpha
- Acadia Pharmaceuticals Presents Additional Phase 2 RADIANT Study Results Evaluating Remlifanserin for the Treatment of Alzheimer's Disease Psychosis at the 2026 Clinical Trials on Alzheimer's Disease (CTAD) Conference
Business Wire
Continue the stock analysis
Jump to another research area for this company.